Sitemap
- Conditions
- Products & Services
-
Education
- EuroPCR 2021 digital – ABIOMED Symposia recordings
- IMP-IT Subgroup analysis on timinig of Impella and outcomes in cardiogenicshock or high-risk percutaneous coronary revascularization now published in: Catheter Cardiovasc Interv. 2021;1–13.
- IMP-IT Subgroup analysis on revascularization extent (R-IMP IT) now published in JACC: Cardiovascular Interventions
- JESFC Congress 2021: ABIOMED Symposia Recording
- Interview Dr. Chieffo - Joint EAPCI /ACVC expert consensus document on percutaneous ventricular assist
- FAQ: Anticoagulation
- Vasileios Panoulas, MD: Restoring EF in Daily Clinical Practice
- Best Practices for Optimizing Impella Use in High-Risk Patients
- European Best Practice: A Step Forward to Optimize Impella-Protected Percutaneous Coronary Intervention to Improve Outcome After High-Risk Coronary Interventions
- Optimized Patient Selection in High-Risk Protected Percutaneous Coronary Intervention
- Standardized Pre-Procedural Clinical Workup for Protected Percutaneous Coronary Intervention
- What Is Known in Pre-, Peri-, and Post-Procedural Anticoagulation in Micro-Axial Flow Pump Protected Percutaneous Coronary Intervention?
- Defining the Optimal Revascularization Strategy During Protected High-Risk Procedures With Impella Heart Pumps
- Handling High-Risk Patients in the Catheterization Laboratory
- Optimal Bail-out and Complication Management Strategies in Protected High-Risk Percutaneous Coronary Intervention With the Impella Heart Pump
- Specific Clinical Vignettes in High-Risk Protected Percutaneous Coronary Intervention
- How to Achieve Better Outcomes in PCCS
- Improving Survival in Cardiogenic Shock — A Propensity Score-Matched Analysis of the Impact of an Institutional Allocation Protocol to Short-Term Mechanical Circulatory Support
- Interview Jürgen Leick: Optimized Patient Selection for High-risk Protected PCI
- Pre-Procedural Clinical Workup for Protected PCI
- Acute Coronary Syndromes and High-Risk PCI: State of the Art (York Part II)
- York Data Analysis: York I vs York II - A Comparison
- Revascularization Completeness with pVAD vs IABP (York Part I)
- ESC 2023: Predictors of 90-day Outcomes from York Analysis
- EHJ Supplement Cardiogenic Shock: Recognizing Patients as Candidates for Mechanical Circulatory Support Along the Spectrum of Cardiogenic Shock
- EACTS 2023 Eghbalzadeh: Awake Insertion of Impella 5.5® with SmartAssist®
- EHJ Supplement Cardiogenic Shock: Timing and Treatment Strategies According to SCAI Classification in Cardiogenic Shock
- EHJ Supplement Cardiogenic Shock: Differential Utilization of Impella Devices, ECMO, and Combined Therapies as Escalation and De-escalation Strategies
- EHJ Supplement-Bernhardt: Escalation and De-escalation Strategies
- EHJ Supplement-Montisci: MCS and the Spectrum of Cardiogenic Shock
- EJH Supplement-Tarantini: Timing and Treatment Strategies for Cardiogenic Shock
- NCSI: Early Utilization of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: The National Cardiogenic Shock Initiative
- Results from the IMPELLA-PL Registry in Poland
- A Decade of Progress in Cardiogenic Shock Treatment: DanGer Shock RCT, a Milestone in CS Trials
- DanGer Shock Results from Dr. Jacob Møller at ACC 2024
- Babar Basir: Importance of Timing to MCS Insertion in Cardiogenic Shock
- Dr. Babar Basir: Best Practices in Revascularization in Cardiogenic Shock
- DanGer Shock Discussion with Jacob Møller at TCT 2024
- 2025 EHJ Supplement: Tharusan Thevathasan – Heart Team Approach to Cardiac Arrest
- 2025 EHJ Supplement: Christophe Vandenbriele – tMCS in Heart Failure
- 2025 EHJ Supplement: PCCS Insights from Ahmad Mahajna
- 2025 EHJ Supplement: Nicoletta D’Ettore – Fulminant Myocarditis
-
Education Library
- EuroPCR 2021 digital – ABIOMED Symposia recordings
- IMP-IT Subgroup analysis on timinig of Impella and outcomes in cardiogenicshock or high-risk percutaneous coronary revascularization now published in: Catheter Cardiovasc Interv. 2021;1–13.
- IMP-IT Subgroup analysis on revascularization extent (R-IMP IT) now published in JACC: Cardiovascular Interventions
- JESFC Congress 2021: ABIOMED Symposia Recording
- Interview Dr. Chieffo - Joint EAPCI /ACVC expert consensus document on percutaneous ventricular assist
- FAQ: Anticoagulation
- Vasileios Panoulas, MD: Restoring EF in Daily Clinical Practice
- Best Practices for Optimizing Impella Use in High-Risk Patients
- European Best Practice: A Step Forward to Optimize Impella-Protected Percutaneous Coronary Intervention to Improve Outcome After High-Risk Coronary Interventions
- Optimized Patient Selection in High-Risk Protected Percutaneous Coronary Intervention
- Standardized Pre-Procedural Clinical Workup for Protected Percutaneous Coronary Intervention
- What Is Known in Pre-, Peri-, and Post-Procedural Anticoagulation in Micro-Axial Flow Pump Protected Percutaneous Coronary Intervention?
- Defining the Optimal Revascularization Strategy During Protected High-Risk Procedures With Impella Heart Pumps
- Handling High-Risk Patients in the Catheterization Laboratory
- Optimal Bail-out and Complication Management Strategies in Protected High-Risk Percutaneous Coronary Intervention With the Impella Heart Pump
- Specific Clinical Vignettes in High-Risk Protected Percutaneous Coronary Intervention
- How to Achieve Better Outcomes in PCCS
- Improving Survival in Cardiogenic Shock — A Propensity Score-Matched Analysis of the Impact of an Institutional Allocation Protocol to Short-Term Mechanical Circulatory Support
- Interview Jürgen Leick: Optimized Patient Selection for High-risk Protected PCI
- Pre-Procedural Clinical Workup for Protected PCI
- Acute Coronary Syndromes and High-Risk PCI: State of the Art (York Part II)
- York Data Analysis: York I vs York II - A Comparison
- Revascularization Completeness with pVAD vs IABP (York Part I)
- ESC 2023: Predictors of 90-day Outcomes from York Analysis
- EHJ Supplement Cardiogenic Shock: Recognizing Patients as Candidates for Mechanical Circulatory Support Along the Spectrum of Cardiogenic Shock
- EACTS 2023 Eghbalzadeh: Awake Insertion of Impella 5.5® with SmartAssist®
- EHJ Supplement Cardiogenic Shock: Timing and Treatment Strategies According to SCAI Classification in Cardiogenic Shock
- EHJ Supplement Cardiogenic Shock: Differential Utilization of Impella Devices, ECMO, and Combined Therapies as Escalation and De-escalation Strategies
- EHJ Supplement-Bernhardt: Escalation and De-escalation Strategies
- EHJ Supplement-Montisci: MCS and the Spectrum of Cardiogenic Shock
- EJH Supplement-Tarantini: Timing and Treatment Strategies for Cardiogenic Shock
- NCSI: Early Utilization of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: The National Cardiogenic Shock Initiative
- Results from the IMPELLA-PL Registry in Poland
- A Decade of Progress in Cardiogenic Shock Treatment: DanGer Shock RCT, a Milestone in CS Trials
- DanGer Shock Results from Dr. Jacob Møller at ACC 2024
- Babar Basir: Importance of Timing to MCS Insertion in Cardiogenic Shock
- Dr. Babar Basir: Best Practices in Revascularization in Cardiogenic Shock
- DanGer Shock Discussion with Jacob Møller at TCT 2024
- 2025 EHJ Supplement: Tharusan Thevathasan – Heart Team Approach to Cardiac Arrest
- 2025 EHJ Supplement: Christophe Vandenbriele – tMCS in Heart Failure
- 2025 EHJ Supplement: PCCS Insights from Ahmad Mahajna
- 2025 EHJ Supplement: Nicoletta D’Ettore – Fulminant Myocarditis
- On-Demand Courses
- Education Programs
- Upcoming Events
-
Resources
-
Downloads
- Resources/Downloads/Impella CP® with SmartAssist® Brochure
- Resources/Downloads/Impella CP® with SmartAssist® Data Sheet
- Resources/Downloads/Impella 5.5® with SmartAssist® Brochure
- Resources/Downloads/Impella 5.5® with SmartAssist® Data Sheet
- Ressources/Downloads/Impella RP® Brochure
- AIC Purge Disc Retainer and Purge Flag
- Resources/Downloads/Impella 5.5® with SmartAssist® Brochure (The nex generation)
- Download Center – Impella 5.5™ with SmartAssist™ Heart Pump
-
Downloads